Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Nausea and Vomiting
Interventions: DRUG: aprepitant|DRUG: cyclophosphamide|OTHER: placebo
Sponsor: UNC Lineberger Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)